The men’s health supplement market has reached a significant inflection point.
The market is valued at roughly $96.74bn in 2026. The industry is experiencing rapid growth, moving from $87.64bn in 2025 to $148.91bn by 2030, with a compound annual growth rate (CAGR) of 10.4%.1
The industry is being reshaped not by flashy marketing but by a more discerning consumer base – one that demands transparency, clinical backing and products that do more than one thing well.
For formulators, researchers and health practitioners, this shift presents both a challenge and an opportunity: developing products that connect traditional notions of male vitality with broader metabolic and long-term wellness goals. The days of single-ingredient, single-benefit formulations are giving way to something more sophisticated – and the science is catching up to meet that demand.
What men are actually looking for in 2026
Three converging trends are defining the space right now, and understanding them is essential for anyone working in product development or clinical practice.
The first trend is hormonal longevity. Men are paying closer attention to how testosterone levels change with age, particularly in relation to andropause and the gradual loss of muscle mass known as sarcopenia. What was once a niche conversation – largely confined to bodybuilding communities and anti-aging clinics – has entered the mainstream.
The conversation has shifted from performance at any cost to sustainable, healthy aging. Men in their 40s, 50s and beyond are actively seeking ways to maintain energy, strength and libido without resorting to synthetic hormone therapies, and the supplement industry is responding accordingly.
The second is metabolic resilience. As rates of lifestyle-related illness continue to rise, there’s growing interest in ingredients that support glucose regulation and energy metabolism – particularly those that appear to mimic some of the metabolic effects of exercise. This reflects how the broader wellness conversation has evolved.
Metabolic health is no longer viewed in isolation as a concern for people managing weight; it’s increasingly understood as a foundational pillar of overall wellbeing, with downstream effects on cardiovascular health, cognitive function, hormonal balance and mood.
The third is gut health. A growing body of research on the microbiome’s influence on mood, weight and energy has brought “inside-out” wellness into the mainstream. Formulators are increasingly examining how digestive health intersects with hormonal and cognitive function.
The gut-brain axis – the bidirectional communication network between the gastrointestinal system and the central nervous system – has become one of the most active areas of nutritional research, and its implications for men’s health are only beginning to be understood.
Underlying all three of these trends is a broader cultural shift: men are increasingly approaching their health proactively rather than reactively. Preventive optimisation, rather than symptom management, is becoming the default mindset among a growing segment of male consumers. That shift changes what they look for in a supplement – and raises the bar for what the industry needs to deliver.
A look at some clinically studied ingredients
Several ingredients have accumulated meaningful clinical evidence in the context of men’s health. What follows is an overview of some of the more well-researched options currently available to formulators.
Testofen®, derived from fenugreek (Trigonella foenum-graecum) and standardised to a saponin glycoside matrix called Fenuside™, has been studied for its effects on free testosterone levels, libido, muscle support and energy. Research has also examined its potential to reduce andropause-related symptoms in men over 40 – making it a relevant option for formulations targeting longevity and active aging.
What distinguishes Testofen from many other testosterone-support ingredients is the depth of its clinical record. Multiple randomised controlled trials have evaluated its efficacy, and the consistency of findings across those studies gives formulators a solid foundation for substantiated product claims. For sports performance, healthspan and vitality categories, it remains one of the more credible options on the market.
Tesnor®, a combination of cocoa bean and pomegranate peel extracts, has shown in clinical studies the ability to influence both free and total testosterone – with some effects observable within as little as two weeks.2-3 It has also been evaluated for its role in supporting muscle strength and reducing aging-male symptom scores.
The relatively rapid onset of measurable effects is clinically significant not only because it speaks to the ingredient’s mechanism of action, but also because it addresses a very practical consumer concern: people want to know whether what they’re taking is working. For formulators developing daily vitality products where perceived efficacy matters for adherence and retention, that speed-to-result profile is worth noting.
ActivAMP®, extracted from Gynostemma pentaphyllum, works through a distinct and particularly interesting pathway. It upregulates sestrins – compounds typically produced during physical exercise – which in turn activate AMP-activated protein kinase (AMPK), a key regulator of cellular energy balance often called the body’s “metabolic master switch”. Studies suggest ActivAMP can support healthy weight management, help maintain triglyceride levels and improve aerobic performance.
Its mechanism of action – essentially mimicking aspects of the physiological response to exercise at the molecular level – makes it especially relevant to the metabolic health category and potentially valuable for men whose lifestyle or physical limitations make consistent exercise difficult.
For R&D teams developing weight management or energy-production formulations, this ingredient’s dual role in fat metabolism and insulin sensitivity offers meaningful formulation flexibility.
Trpti™ is a bioavailable form of Oleoylethanolamide (OEA), a naturally occurring lipid messenger involved in appetite regulation and gut health. As interest in natural satiety solutions rises – partly in response to the significant mainstream attention given to GLP-1 receptor agonists – OEA’s role in the gut-brain axis has drawn increased research focus.
Unlike stimulant-based appetite suppressants, OEA signals satiety via a lipid-sensing pathway in the small intestine, communicating fullness cues to the brain without the side-effect profile associated with synthetic compounds.
For formulators seeking to address weight management in a way that aligns with the growing demand for cleaner, more natural interventions, this mechanism offers a scientifically grounded, commercially timely option. Emerging microbiome research is also beginning to illuminate OEA’s broader role in gut-immune interactions, which could open additional formulation angles as that science matures.
AGEprost™, an extract of Ageratum conyzoides, has been studied specifically for prostate health and bladder control – areas of significant concern for aging men that are often underserved by general vitality formulations. Prostate health tends to become a meaningful quality-of-life issue for men in their 50s and beyond, and ingredients with credible evidence in this area fill an important gap in the broader men’s health portfolio.
Levagen®+, a branded form of palmitoylethanolamide (PEA), has a growing body of evidence supporting muscle recovery, exercise-induced inflammation, sleep quality and cognitive support. One recent study found that PEA supplementation during eight weeks of strength training helped preserve lean mass and meaningfully increased lower-body power output compared with placebo.4
PEA’s multi-system profile – spanning musculoskeletal recovery, neurological function and sleep – makes it a particularly versatile ingredient for formulators developing comprehensive wellness or active-aging products, where the goal is broad physiological support rather than a single targeted outcome.
The case for multifunctional formulation
One pattern worth noting in this overview is that many of these ingredients address more than one physiological system. Testofen influences both hormonal balance and stress. ActivAMP affects both metabolic regulation and exercise performance. Levagen®+ spans recovery, sleep and cognitive function.2-4 This is not coincidental – it reflects how these systems interact in the body and is increasingly reflected in how consumers think about their health.
The era of hyper-siloed supplementation – one pill for testosterone, another for weight, another for sleep – is giving way to demand for formulations that recognise the interconnected nature of male physiology. Hormonal health affects metabolism. Metabolic health affects mood and energy. Sleep quality affects hormonal output. These relationships are well established in the clinical literature, and products designed with them in mind are better positioned to deliver outcomes that consumers can actually feel.
For formulators, this supports moving away from minimum-effective-dose, maximum-ingredient-count labeling strategies toward fewer, better-studied ingredients at therapeutic dosages. The clinical evidence is clearest at the doses used in trials – and that’s where product performance is most defensible to regulators and consumers alike.
Why clinical evidence has become the real differentiator
In a market this large and competitive, the distinction between products that work and those that merely claim to work has never mattered more. Regulatory scrutiny is increasing, consumers are more skeptical and retailers are paying closer attention to the science behind what they stock.
The Federal Trade Commission and its international counterparts have become more active in pursuing supplement companies that make unsubstantiated claims, and the reputational cost of a poorly supported product has risen alongside that enforcement environment. At the same time, the rise of health-focused media, independent testing organisations and consumer review platforms means that products are being evaluated more rigorously than ever, even outside official channels.
For anyone developing in this space, the practical implication is straightforward: formulations grounded in peer-reviewed, placebo-controlled research are better positioned to earn lasting consumer trust than those relying on tradition or marketing alone. That means investing in randomised, double-blind trial data where possible, specifying the doses at which effects have been demonstrated and being honest about the limits of what the evidence currently supports.
The trend toward therapeutic dosages – rather than token inclusions of trending ingredients – – reflects the same underlying demand for honesty and efficacy. A product that contains a clinically studied ingredient at a fraction of the studied dose is not clinically supported. That distinction matters, and consumers are increasingly equipped to make it.
Looking ahead
Men’s health as a category is maturing. The supplements that will define the next phase of this market are likely to be grounded in biology, not buzzwords – products that respect the complexity of male physiology, acknowledge the interconnectedness of hormonal, metabolic, and gut health and support their claims with evidence that holds up to scrutiny.
The science is there. The consumer demand is there. The remaining question is whether the industry’s formulation practices will rise to meet both demands.
References
- Research and Markets. Men’s Health Supplements Market Report 2026.
- Sreeramaneni, PGA.; et al. A Proprietary Herbal Blend Containing Extracts of Punica granatum Fruit Rind and Theobroma cocoa Seeds Increases Serum Testosterone Level in Healthy Young Males: A Randomized, Double-Blind Placebo-Controlled Study. J Diet Suppl. 2022 Feb 6:1-17.
- Srivastava, MK.; et al. A Combination of Punica granatum Fruit Rind and Theobroma cacao Seed Extracts Enhances Sexual Function in Aging Males in a Randomized, Double-blind, Placebo-controlled Study. Int J Med Sci. 2025; 22(2):383-397.
- Huschtscha, Z.; et al. The Effect of Palmitoylethanolamide (PEA) on Skeletal Muscle Hypertrophy, Strength, and Power in Response to Resistance Training in Healthy Active Adults: A Double-Blind Randomized Control Trial. Sports Med. 2024; Open 10, 66.
